Neutral Phosphate for Kidney Stones

MP
Overseen ByMegan Prochaska, MD
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: University of Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Kidney stones are common and often come back. One reason may be that some people with calcium stones have low phosphate levels in the blood and lose too much phosphate through the kidneys. They may also have high calcium in the urine, which raises the chance of forming stones. In older studies, high doses of phosphate supplements lowered urine calcium and appeared to reduce stone formation, but they sometimes caused stomach and bowel side effects, and phosphate is no longer used for stone prevention. This small pilot study will test a much lower dose of neutral phosphate (250 mg twice daily) for 2 weeks in adults with recurrent calcium oxalate kidney stones, high urine calcium, and low blood phosphate. Participants will collect a 24-hour urine sample and have blood drawn before and after the 2-week period. The study will look at whether the low dose reduces urine calcium and the risk of stone formation in urine. The results will help decide whether a larger study is warranted.

Are You a Good Fit for This Trial?

This trial is for adults who have had repeated calcium oxalate kidney stones, have high calcium in their urine, and low phosphate levels in their blood.

Inclusion Criteria

Hypercalciuria (>250mg/day)
Hypophosphatemia (<3mg/dL)
I am between 18 and 70 years old.
See 1 more

Exclusion Criteria

I have been diagnosed with complete distal renal tubular acidosis.
Very low (less than 100mg/day) or very high (greater than 1500mg/day) urine phosphate
I need to keep taking my diuretic or alkali supplements during the study.
See 4 more

What Are the Treatments Tested in This Trial?

Interventions

  • Neutral Phosphate

Trial Overview

The study tests if taking a low dose of neutral phosphate (250 mg twice daily for 2 weeks) can lower urine calcium and reduce the risk of new kidney stones. Participants provide urine and blood samples before and after treatment.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Neutral Phosphate 250 mg Twice DailyExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Chicago

Lead Sponsor

Trials
1,086
Recruited
844,000+